Document is current
Any future updates will be listed below
-
Authors
Kidd, Kendrah O.
Williams, Adrienne H.
Taylor, Abbigail
Martin, Lauren
Robins, Victoria
Sayer, John A.
Olinger, Eric
Mabillard, Holly R.
Papagregoriou, Gregory
Deltas, Constantinos
Stavrou, Christoforos
Conlon, Peter J.
Hogan, Richard Edmund
Elhassan, Elhussein A.E.
Springer, Drahomíra
Zima, Tomáš
Izzi, Claudia
Vrbacká, Alena
Piherová, Lenka
Pohludka, Michal
Radina, Martin
Vylet’al, Petr
Hodanova, Katerina
Zivna, Martina
Kmoch, Stanislav
Bleyer, Anthony J. Sr.
-
Funding
Funding for this research was provided by:
Medical Research Council
The Slim Health Foundation
European Union’s Horizon 2020 Program
Government of Cyprus and the University of Cyprus (857122)
Royal College of Surgeons of England (StAR PhD)
OP Integrated Infrastructure (ITMS: 313011ATA2)
European Regional Development Fund and by the Slovak Research and Development Agency (PP-COVID-20-0056)
Ministry of Health of the Czech Republic (NU21-07-00033)
Ministerstvo Zdravotnictví Ceské Republiky (NU22-A-123)
Ministry of Education of the Czech Republic (LTAUSA19068)
Univerzita Karlova v Praze (UNCE/MED/007)
National Center for Medical Genomics (LM2023067)
Black Brogan Foundation
Soli Deo Gloria
National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK103225)
- License Information
-
More Information
Article History
Received: 10 July 2024
Accepted: 27 November 2024
First Online: 18 December 2024
Declarations
:
: This study was approved by the Wake Forest University Health Sciences Institutional Review Board, Winston-Salem, NC, United States, in accordance with the Declaration of Helsinki. All individuals presented in the study provided voluntary, autonomous consent to participate.
: Not applicable.
: AJB has also received funding from the Black Brogan Foundation, The Slim Health Foundation, Soli Deo Gloria. He has received compensation as follows: advisory board, Horizon Pharma; speaker, Natera; author, UpToDate; advisor, First Faculty of Medicine, Charles University; royalty; patent for UMOD genetic diagnosis. PJC has received funding from Astra Zeneca, Bohringher, Hansa, and medical advisory board fees. KOK, AHW, AT, AK, LM, VR, APR-C, JAS, EO, HRM, GP, CD, CS, REH, EE, DS, CI, AV, LP, TZ, MP, MR, PV, KH, MZ, and SK have nothing to disclose.
